Answers are grounded in this paper and cite their sources.
Five parkinsonian patients with severe “on-off” effects from levodopa therapy also were given combination carbidopa/levodopa. Serial half-hourly measurements of plasma levels of dopa, 3-O-methyldopa, and homovanillic acid showed partial concordance between clinical fluctuation and plasma dopa levels in patients receiving levodopa alone or in combination with carbidopa. The combination therapy does not lessen “on-off” effects except when administered in greater and more-frequent doses, which are permitted by the improved gastrointestinal tolerance with carbidopa/levodopa. A single intramuscular injection of pyridoxine has no clinical effect and slightly lowers subsequent plasma dopa only in the absence of carbidopa. Possible biochemical mechanisms are discussed.
No takes yet. Share an insight, caveat, or question.
Stanley Fahn (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: